| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -2,151,070 | -1,373,105 |
| Loss on disposal of fixed assets | - | 0 |
| Stock-based compensation expense and warrant expense | 1,740,727 | 1,113,334 |
| Depreciation and amortization | 631,326 | 426,844 |
| Accounts receivable | -308,749 | -791,679 |
| Inventory | 1,608,041 | 1,144,174 |
| Prepaid expenses and other assets | 104,520 | -379,330 |
| Other liabilities | -26,379 | 74,833 |
| Accounts payable | 222,193 | -555,430 |
| Accrued payroll and related taxes | -355,335 | -122,459 |
| Non-cash lease adjustments | - | 0 |
| Accrued expenses | 709,999 | -288,659 |
| Net cash used in operating activities | -632,351 | -697,807 |
| Purchases of property and equipment | 524,735 | 472,252 |
| Purchases of intangible assets | 3,400 | 3,400 |
| Net cash used in investing activities | -528,135 | -475,652 |
| Proceeds from exercise of employee stock options | 89,025 | - |
| Borrowings from insurance finance indebtedness | 406,751 | -271,152 |
| Payments on insurance finance indebtedness | -342,972 | - |
| Payments on finance lease liability | 81,710 | 54,084 |
| Payments for taxes related to net share settlement of equity awards | 27,536 | 27,536 |
| Net cash provided by (used in) financing activities | 43,558 | -352,772 |
| Net decrease in cash and cash equivalents | -1,116,928 | -1,526,231 |
| Cash and cash equivalents at beginning of period | 9,580,947 | - |
| Cash and cash equivalents at end of period | 8,464,019 | - |
KORU Medical Systems, Inc. (KRMD)
KORU Medical Systems, Inc. (KRMD)